Role of NFAT in the vascular endothelium
Role of NFAT in the vascular endothelium
批准号:
MR/S01019X/1
负责人:
Sarah De Val
金额:
$82.71万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The calcineurin-NFAT signaling pathway is involved in many important processes in our bodies. In particular, we know a lot about the crucial role this pathway plays in the immune system, where it switches on and off many key genes. However, less is known about what it does in other parts of the body. I am interested in understanding the control of blood vessel formation. This work focuses on endothelial cells, which form the inner lining of all vessels and are the first part of blood vessels to form. When NFAT signaling is inhibited, blood vessels do not form correctly. We recently examined mouse embryos that had lost NFAT signaling in the endothelium, and found that they have healthy arteries but defective veins. Arteries transport oxygen-rich blood to capillaries, while veins return the blood to the heart. Although vein endothelial cells are already known to be very different from their arterial counterparts, we do not understand how vein formation and growth is regulated. Based on the observations that veins were not formed correctly in NFAT mutant embryos, we looked at the binding pattern of the NFAT protein NFATc1. This revealed that NFATc1 binds directly to the enhancers (on-off switches) of many genes that are required for vein formation, suggesting that NFAT signaling may directly switch these on. In the project, we will analyse mouse and zebrafish embryos with defective NFAT signaling to establish why veins do not form properly. We will also investigate the enhancers that bind NFATc1 to both understand which genes are directly bound and activated by NFAT, and to find the other proteins which help NFAT function. Lastly, we will also find out how NFATc1 is itself able to switch on specifically in vein endothelial cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41467-021-23660-5
发表时间:
2021-06-08
期刊:
Nature communications
影响因子:
16.6
作者:
[Kalisch-Smith JI, Ved N, Szumska D, Munro J, Troup M, Harris SE, Rodriguez-Caro H, Jacquemot A, Miller JJ, Stuart EM, Wolna M, Hardman E, Prin F, Lana-Elola E, Aoidi R, Fisher EMC, Tybulewicz VLJ, Mohun TJ, Lakhal-Littleton S, De Val S, Giannoulatou E, Sparrow DB]
通讯作者:
Sparrow DB
DOI:
10.1007/978-1-0716-2059-5_28
发表时间:
2022
期刊:
Methods in molecular biology
影响因子:
--
作者:
[A. Neal;H. Rodriguez-Caro;S. De Val]
通讯作者:
A. Neal;H. Rodriguez-Caro;S. De Val
Regulatory pathways controlling venous identity
-
批准号:BB/L020238/1
-
项目类别:Research Grant
-
资助金额:$67.29万
-
财政年份:2014
-
负责人:Sarah De Val
-
依托单位:
Transcriptional regulation of the Notch and Vegf signalling pathways during angiogenesis and arterio-venous differentiation
-
批准号:MR/J007765/1
-
项目类别:Research Grant
-
资助金额:$66.58万
-
财政年份:2012
-
负责人:Sarah De Val
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NFAT5-PAI-1轴通过促进心肌细胞铜死亡参与超负荷诱导的心力衰竭心肌重塑
-
批准号:2026JJ82100
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:白杨
-
依托单位:
扶正解毒汤通过抑制HIF-1α介导的巨噬细胞糖酵解并经PD-1/NFAT通路恢复T细胞活性减轻脓毒症免疫抑制的机制研究
-
批准号:2026JJ82523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李波
-
依托单位:
靶向Sox9/Wnt5a/NFAT信号轴促进睑板腺再生以治疗终末期睑板腺功能障碍的策略与机制研究
-
批准号:2025JJ90130
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭俞利
-
依托单位:
LINC01426/NFAT5复合体通过糖酵解途径重塑方式驱动肺腺癌恶性进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:方启宇
-
依托单位:
Orai1/CaN/NFAT2钙信号轴在磷酸盐引起
的冠脉平滑肌细胞凋亡和钙化中的作用
及小分子抑制剂研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:沈兵
-
依托单位:
乳酸通过激活Ca2+/NFAT1轴驱动Treg细胞上调CCR8促进肿瘤进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡超
-
依托单位:
TRIM25/GSK3β/NFAT正反馈环路促上皮间充质转化(EMT)介导胶质瘤侵袭进展的机制研究
-
批准号:JCZRYB202500967
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
CD156/ITGAM/NFAT1信号轴介导损伤感觉神经元对巨噬细胞促炎激活在三叉神经痛中的作用与机制研究
-
批准号:Z25H090013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:姜保春
-
依托单位:
SP1调控CIB1/CIB2表达失衡激活钙调神经磷酸酶-NFAT通路促进脓毒症新发房颤的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:洪江
-
依托单位:
NFAT4调控血管平滑肌细胞亚群转化在血管内膜增生疾病中的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:刘秀
-
依托单位: